Evidence map›Paper›PMID 33178189›Full record

ArticleFrontiers in immunology2020

Spatiotemporal Alterations in Gait in Humanized Transgenic Sickle Mice.

Stacy Kiven, Ying Wang, Anupam Aich, Donovan A Argueta, Jianxun Lei, Varun Sagi, Madhushan Tennakoon, Saad J Bedros, Nils Lambrecht, Kalpna Gupta

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pain in Hemophilia: Unexplored Role of Oxidative Stress.Antioxidants (Basel, Switzerland) · 2022
    Review
  6. Sickle cell disease as an accelerated aging syndrome.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  7. Review
  8. Pain in sickle cell disease: current and potential translational therapies.Translational research : the journal of laboratory and clinical medicine · 2021
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Stacy KivenHematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA, United States.
Ying WangDepartment of Anesthesia, Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, IN, United States.
Anupam AichHematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA, United States.
Donovan A ArguetaHematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA, United States.
Jianxun LeiDivision of Hematology, Oncology and Transplantation, Department of Medicine, Vascular Biology Center, University of Minnesota, Minneapolis, MN, United States.
Varun SagiDivision of Hematology, Oncology and Transplantation, Department of Medicine, Vascular Biology Center, University of Minnesota, Minneapolis, MN, United States.
Madhushan TennakoonDivision of Hematology, Oncology and Transplantation, Department of Medicine, Vascular Biology Center, University of Minnesota, Minneapolis, MN, United States.
Saad J BedrosCollege of Science & Engineering, University of Minnesota, Minneapolis, MN, United States.
Nils LambrechtPathology and Laboratory Medicine, Long Beach VA Healthcare System, Long Beach, CA, United States.
Kalpna GuptaHematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA, United States.
University of Minnesota · USUniversity of California, Irvine · USIndiana University School of MedicineVA Long Beach Healthcare System · US

Funding

Targeting mechanisms contributing to vascular dysfunction and pain in sickle cell diseaseR01HL147562 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI GUPTA, KALPNA · 2019 to 2022
$3.4M
Treating pain in sickle cell disease by means of focused ultrasound neuromodulationU18EB029354 · NIBIB · CARNEGIE-MELLON UNIVERSITY · PI HE, BIN · 2019 to 2019
$2.0M
NHLBI NIH HHS R01 HL147562NIBIB NIH HHS U18 EB029354
6 · The paper itself

Abstract

Sickle cell disease (SCD) is a hemoglobinopathy affecting multiple organs and featuring acute and chronic pain. Purkinje cell damage and hyperalgesia have been demonstrated in transgenic sickle mice. Purkinje cells are associated with movement and neural function which may influence pain. We hypothesized that Purkinje cell damage and/or chronic pain burden provoke compensatory gait changes in sickle mice. We found that Purkinje cells undergoe increased apoptosis as shown by caspase-3 activation. Using an automated gait measurement system, MouseWalker, we characterized spatiotemporal gait characteristics of humanized transgenic BERK sickle mice in comparison to control mice. Sickle mice showed alteration in stance instability and dynamic gait parameters (walking speed, stance duration, swing duration and specific swing indices). Differences in stance instability may reflect motor dysfunction due to damaged Purkinje cells. Alterations in diagonal and all stance indices indicative of hesitation during walking may originate from motor dysfunction and/or arise from fear and/or anticipation of movement-evoked pain. We also demonstrate that stance duration, diagonal swing indices and all stance indices correlate with both mechanical and deep tissue hyperalgesia, while stance instability correlates with only deep tissue hyperalgesia. Therefore, objective analysis of gait in SCD may provide insights into neurological impairment and pain states.

Indexed as

alpha-GlobinsAnemia, Sickle CellAnimalsApoptosisbeta-GlobinsBrainCaspase 3Chronic PainDisease Models, AnimalGaitGene Knockout TechniquesHumansHyperalgesiaMiceMice, TransgenicPhenotypealpha-Globinsbeta-GlobinsCasp3 protein, mouseCaspase 3gaithistopathologyhyperalgesiapurkinje cellsickle cell disease

Identifiers

PMID33178189
PMCPMC7593487
OpenAlexW3098490859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.